https://www.selleckchem.com/pr....oducts/ulixertinib-b
tients following PCI. Therefore, a close follow-up should be targeted in such patients.Pancreatic cancer (PC) is a highly malignant tumor type with a high early metastasis rate and no obvious symptoms. Gemcitabine is a first-line chemotherapeutic drug for PC. Since there is no distinct method to determine the efficacy of chemotherapy with gemcitabine in patients with PC, the purpose of the present study was to determine whether positivity for circulating tumor cells (CTCs) in patients with advanced PC is associated
Like
Comment
Share
